Simultaneous determination of water- and fat-soluble vitamins in tablets and energy drinks by using a novel Vanquish Flex Duo system for Dual LC

Similar documents
Doubling the throughput of long chromatographic methods by using a novel Dual LC workflow

Rapid and sensitive UHPLC screening for water soluble vitamins in sports beverages

Rapid and sensitive UHPLC screening of additives in carbonated beverages with a robust organic acid column

Determination of Water- and Fat-Soluble Vitamins in Nutritional Supplements by HPLC with UV Detection

Application Note. Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice. Author. Abstract.

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

Application Note. Agilent Application Solution Analysis of fat-soluble vitamins from food matrix for nutrition labeling. Abstract.

Measuring Phytosterols in Health Supplements by LC/MS. Marcus Miller and William Schnute Thermo Fisher Scientific, San Jose, CA, USA

ASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC

Detection of oxygenated polycyclic aromatic hydrocarbons (oxy-pahs) in APCI mode with a single quadrupole mass spectrometer

Pelagia Research Library

ISSN: ; CODEN ECJHAO E-Journal of Chemistry 2011, 8(3),

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

Robust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS

Impurity Profiling of Carbamazepine by HPLC/UV

Rapid determination of phosphate and citrate in carbonated soft drinks using ion chromatography

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

Two-dimensional HPLC determination of water-soluble vitamins in a nutritional drink

Journal of Chemical and Pharmaceutical Research, 2017, 9(9): Research Article

LC-MS/MS Method for the Determination of Tenofovir from Plasma

Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method

Comparison of a UPLC Method across Multiple UHPLC Systems

Concurrent analysis of fat and water soluble vitamins in biological fluids using reverse phase-high performance liquid chromatography technique

Development and validation of stability indicating RP-LC method for estimation of calcium dobesilate in pharmaceutical formulations

HPLC to UHPLC Transfer of USP Method for Amlodipine Besylate Using the Agilent 1290 Infinity II LC

Analysis of Amino Acids Derived Online Using an Agilent AdvanceBio AAA Column

ISSN (Print)

Pelagia Research Library

RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form

Title Revision n date

METHOD DEVELOPMENT AND VALIDATION BY RP-HPLC FOR ESTIMATION OF ZOLPIDEM TARTARATE

A Robustness Study for the Agilent 6470 LC-MS/MS Mass Spectrometer

Development and validation of RP-HPLC method for simultaneous estimation of gliclazide and metformin in pure and tablet dosage form

F. Al-Rimawi* Faculty of Science and Technology, Al-Quds University, P.O. Box 20002, East Jerusalem. Abstract

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms

Analysis of Counterfeit Antidiabetic Drugs by UHPLC with the Agilent 1220 Infinity Mobile LC

Development and Validation of a Simultaneous HPLC Method for Quantification of Amlodipine Besylate and Metoprolol Tartrate in Tablets

Transferring a Method for Analysis of DNPH-Derivatized Aldehydes and Ketones from HPLC to UHPLC

SPE-LC-MS/MS Method for the Determination of Nicotine, Cotinine, and Trans-3-hydroxycotinine in Urine

Fast and easy separation of 23 drugs of abuse. including high, stable resolution of isobaric opioids from human urine by UHPLC-MS/MS

Extended Application Note

Qualitative and quantitative determination of phenolic antioxidant compounds in red wine and fruit juice with the Agilent 1290 Infinity 2D-LC Solution

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

World Journal of Pharmaceutical Research

Quetiapine Tablets. Expert Committee Monographs Chemical Medicines 4 Reason for Revision Compliance

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

Analysis of Vitamins Using an SFC/UHPLC Hybrid System with a Triple Quadrupole LC/MS for Quantification

This revision also necessitates a change in the table numbering in the test for Organic Impurities.

USP purity analysis of pravastatin sodium using the Agilent 1120 Compact LC

Shuguang Li, Jason Anspach, Sky Countryman, and Erica Pike Phenomenex, Inc., 411 Madrid Ave., Torrance, CA USA PO _W

Application Note. Small Molecule Pharmaceuticals. 2-Ethyl-2-phenylmalonamide Ethosuximide Primidone Carbamazepine. Carbamazepine-

Development and Validation of a Polysorbate 20 Assay in a Therapeutic Antibody Formulation by RP-HPLC and Charged Aerosol Detector (CAD)

Scholars Research Library. Der Pharmacia Lettre, 2016, 8 (6): (

Selectivity Comparison of Agilent Poroshell 120 Phases in the Separation of Butter Antioxidants

CHAPTER 2 SIMULTANEOUS DETRMINATION OF ANASTROZOLE AND TEMOZOLOMIDE TEMOZOLOMIDE CAPSULES 20 MG AND ANASTROZOLE TABLETS 1 MG

IJRPC 2013, 3(2) Nagamallika et al. ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

2D-LC as an Automated Desalting Tool for MSD Analysis

DETERMINATION OF OXYCODONE CONTENT AND RELATED SUBSTANCES IN OXYCODONE AND ACETAMINOPHEN CAPSULE BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY

Estimation of Zanamivir Drug present in Tablets using RP-HPLC Method

Relative Measurement of Zeaxanthin Stereoisomers by Chiral HPLC

Rapid Gradient and Elevated Temperature UHPLC of Flavonoids in Citrus Fruit

Scholars Research Library

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

Mass-Based Purification of Natural Product Impurities Using an Agilent 1260 Infinity II Preparative LC/MSD System

Analysis of Isoflavones with the PerkinElmer Flexar FX-15 UHPLC System Equipped with a PDA Detector

Simultaneous Estimation of Gemcitabine Hydrochloride and Capecitabine Hydrochloride in Combined Tablet Dosage Form by RP-HPLC Method

A New Stability-Indicating and Validated RP-HPLC Method for the Estimation of Liraglutide in Bulk and Pharmaceutical Dosage Forms

Research Article Simultaneous Estimation of DL-Methionine and Pyridoxine Hydrochloride in Tablet Dosage Form by RP-HPLC

Hyderabad, India. Department of Pharmaceutical Chemistry, Glocal University, Saharanpur, India.

Effective use of Pharmacopeia guidelines to reduce cost of chromatographic analysis for Fluticasone propionate

Journal of Chemical and Pharmaceutical Research

Development, Estimation and Validation of Lisinopril in Bulk and its Pharmaceutical Formulation by HPLC Method

Cannabinoid Profiling and Quantitation in Hemp Extracts using the Agilent 1290 Infinity II/6230B LC/TOF system

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF LACOSAMIDE IN BULK AND ITS PHARMACEUTICAL FORMULATION

Validation of Changes to the USP Assay Method for Ibuprofen Tablets

Analysis of Common Sweeteners and Additives in Beverages with the PerkinElmer Flexar FX-15 System Equipped with a PDA Detector

Journal of Chemical and Pharmaceutical Research, 2018, 10(3): Research Article

Comparison of conventional HPLC with UPLC method for determination of albuterol sulfate and it s impurities in pharmaceutical formulation

Journal of Chemical and Pharmaceutical Research

International Journal of Pharma and Bio Sciences DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF STRONTIUM RANELATE IN SACHET

Application Note. Authors. Abstract. Food

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

Analysis of bisphenol A leaching from baby feeding bottles

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

Determination of Tigecycline in a Cell Lysate

Maximizing chromatographic peak capacity with the Agilent 1290 Infinity LC system

PAPRIKA EXTRACT SYNONYMS DEFINITION DESCRIPTION FUNCTIONAL USES CHARACTERISTICS

SIMULTANEOUS ESTIMATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE IN TABLETS BY RP-HPLC METHOD

Scholars Research Library

Journal of Chemical and Pharmaceutical Research, 2013, 5(1): Research Article

RP- HPLC and Visible Spectrophotometric methods for the Estimation of Meropenem in Pure and Pharmaceutical Formulations

Available online at Scholars Research Library

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS TOLBUTAMIDE IN PURE AND PHARMACEUTICAL FORMULATIONS

New RP-HPLC Method for the Determination of Fludarabine in Pharmaceutical Dosage Forms

Two-Dimensional HPLC Determination of Water-Soluble Vitamins in a Nutritional Drink

ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS

Agilent 1260 Infinity Analytical SFC System

Transcription:

APPLICATION NOTE 72592 Simultaneous determination of water- and fat-soluble vitamins in tablets and energy drinks by using a novel Vanquish Flex Duo system for Dual LC Authors Sylvia Grosse, Mauro De Pra, Frank Steiner Thermo Fisher Scientific, Germering, Germany Keywords Water-soluble vitamins, fat-soluble vitamins, food quality, food safety, food, beverages, supplements, Acclaim PolarAdvantage II column, Vanquish Flex Duo system for Dual LC Application benefits Workflow provides quantitative analysis of fat-soluble and water-soluble vitamins in drinks and food supplement tablets using the Thermo Scientific Vanquish Flex Duo UHPLC system for Dual LC. Workflow enables running two separate methods and columns in one instrument, simultaneously. Goal To describe a workflow for the simultaneous quantitative analysis of fatsoluble and water-soluble vitamins in drinks and food supplement tablets using the Vanquish Flex Duo system for Dual LC and the Thermo Scientific Acclaim PolarAdvantage II column. Introduction Vitamins are essential nutrients found in various natural food sources and food supplements. Vitamins can be classified as water-soluble vitamins (WSV) or fat-soluble vitamins (FSV), based on their hydrophobicity. Reversed-phase high-performance liquid chromatography is widely used to determine vitamins in food, supplements, and beverages. Because of the dramatically different hydrophobicity of WSV and FSV, simultaneous liquid chromatography analysis with the same method is difficult. While some WSV are poorly retained in

reversed-phase even with very weak mobile phases, the FSV will elute only with very strong solvents, approaching 100% organic. A reversed-phase method, applicable for a wide range of polarities and at the same time providing an acceptable compromise in terms of resolution and runtime, is not easily implemented. A method for the separation of FSV and WSV was proposed where two columns were operated sequentially in one system. 1 For this approach, a conventional LC system had to be fitted with a pair of switching valves to connect the selected column to the injector and UV detector. The method was effective since the analysis of both vitamin classes could be run unattended. However, this solution required complex hardware setup, and even more complex chromatography data system programming. Additionally, since the columns were run after the other, throughput was low. Other advanced applications are reported in the literature for the simultaneous analysis of both vitamin classes. For instance, one approach for the separation of FSV and WSV in the same column and with the same method made use of delayed injection of the sample expected to contain FSV. 2 This way, the highly hydrophobic FSV entered the column only when the strength of the mobile phase was sufficiently high. The method depended on the flexibility of the chromatography data system and of the UHPLC system. The complexity of programming and instrument setup made the implementation of this approach somewhat cumbersome. In this work we introduce an effective workflow for the simultaneous analysis of WSV and FSV that overcomes challenges of all previously reported approaches. The workflow is based on a novel Vanquish Flex Duo system for Dual LC. The system consists of a Dual Pump F with two independent flow paths, a Dual Split Sampler FT with two separate injection ports and sample loops, one or optionally two Column Compartments H, and two detection systems. It enables the independent and simultaneous use of two different columns and methods. Thanks to these advanced features, two independent methods were developed and optimized for FSV and WSV and run simultaneously. The Dual LC workflow delivers much higher throughput compared to the column switching approach mentioned previously. 1 Moreover, potential issues such as incompatibility of the mobile phases in the shared flow path are eliminated one example of such an issue is precipitation of buffer salts in high-organic solvent. Compared to the former solution, the approach with the Vanquish Flex Duo system for Dual LC presented here is remarkably simple to implement, allows the use of better optimized methods, and increases throughput thanks to the simultaneous use of two columns with two methods and faster analysis cycles. For both vitamin classes, the reversed-phase column chosen to run the Dual LC workflow is the Acclaim PolarAdvantage II (PA2) column. The column features a polar-embedded stationary phase that effectively operates over a wide range of mobile phase conditions and is highly suitable for the separation of components with very diverse hydrophobicity, such as vitamins. Experimental Chemicals Deionized (DI) water 18 MΩ cm resistivity or higher Acetonitrile, Optima LC/MS grade (Fisher Scientific P/N 100001334) Methanol, Optima LC/MS grade (Fisher Scientific P/N 10767665) Acetic acid, Optima LC/MS grade (Fisher Scientific P/N 10860701) Ortho-phosphoric acid, HPLC grade (P/N 10644732) DMSO, HPLC grade, (P/N 10387791) Hexane, HPLC grade, (P/N 10703611) Ethanol, HPLC grade, (P/N 10542382) Acetone, HPLC grade, (P/N 10131560) Potassium dihydrogen phosphate, p.a. (purchased from a reputable vendor) Potassium hydroxide, p.a. (purchased from a reputable vendor) Potassium bicarbonate, p.a. (purchased from a reputable vendor) Water-soluble vitamins: ascorbic acid, cyanocobalamine, folic acid, nicotinamide, pantothenic acid, pyridoxal, pyridoxine, thiamine, riboflavin; analytical grade (purchased from a reputable vendor) Fat-soluble vitamins: cholecalciferol, ergocalciferol, phyllochinone, α-tocopherole, α-tocopherole acetate, δ-tocopherole, γ-tocopherole, retinol, retinol acetate, retinol palmitate; analytical grade (purchased from a reputable vendor) 2

Equipment ph meter, Thermo Scientific Orion 3-Star Ultrasonic bath with temperature regulation, Fisher Scientific Magnetic stirrer, Fisher Scientific Syringe filter, Minisart cellulose acetate (CA) (Ø 26 mm; 0.45 µm pore size), (purchased from a reputable vendor) Conical tubes (50 ml), Fisher Scientific (P/N 10788561) Vials (amber, 2 ml), Fisher Scientific (P/N 15508760) Septa (Silicone/PTFE), Fisher Scientific (P/N 11548180) Preparation of standards Stock solutions of each water-soluble vitamin (thiamine, ascorbic acid, pyridoxal, pyridoxin, nicotinamide, pantothenic acid, and cyanocobalamin) at a concentration of 1 mg/ml were prepared using water. Folic acid was dissolved in 20 mm KHCO 3 and riboflavin in 5 mm KOH, as they are not stable in pure water. Stock solutions of each fat-soluble vitamin (retinol, retinol acetate, retinol palmitate, ergocalciferol, cholecalciferol, δ-tocopherole, γ-tocopherole, α-tocopherole, and α-tocopherole acetate) at a concentration of 1 mg/ml were prepared using methanol. Menaquinone and phyllochinone were prepared using acetone instead of methanol due to better solubility. Calibration standards were prepared at eight concentrations 100, 50, 25, 10, 5, 1, 0.5, and 0.1 µg/ml using water for the water-soluble vitamins and methanol for the fat-soluble ones. Thiamine was calibrated using the standard addition method in the concentration range of 5 µg/ml to 100 µg/ml by adding the appropriate amount of the 1 mg/ml stock solution to the extract of the prepared sample of WSV. All standards and samples were filled into HPLC brown glass vials and sealed properly to protect the solutions from light and evaporation. Sample preparation of a vitamin tablet and an energy drink The vitamin tablet and the placebo tablet (used as a matrix blank and for the determination of recovery) were bought from a local pharmacy. The energy drink was purchased from a local supermarket. A slightly different sample preparation protocol 3 is here described. Water-soluble vitamins in the vitamin tablet One vitamin tablet was weighed and ground with a mortar and pestle. The powder was transferred into a 250 ml bottle and the weight noted. Ten milliliters of DMSO were added to the bottle and then sonicated for 2 min. Next, 90 ml of 2% acetic acid in water were added to the solution and then stirred for 1 min. Afterwards, the sample was extracted by sonication; for this purpose, the sonicator was set at 40 C for 5 min. The solution was then filtered through a CA syringe filter with 0.45 µm pore size. An aliquot was diluted 1:10 with water. The undiluted and diluted solutions were used for quantification, depending on the expected amount of analyte in the sample. The same procedure was followed with a placebo tablet. The placebo tablet was analyzed without adding vitamin standard for matrix background subtraction. In addition, it was spiked with 10 µg/ml of a vitamin standard mixture to calculate the recovery rate of each analyte. For this purpose, 10 ml of a 100 µg/ml standard solution were added to the powdered tablet, shaken, and then incubated without shaking for 3 min. Afterwards, 10 ml of DMSO and 80 ml of 2% acetic acid solution were added so that the final sample volume was the same volume as the real samples. The sample preparation procedure was the same as described for the vitamin tablet. All samples were prepared in three replicates and analyzed immediately after preparation. Water-soluble vitamins in the beverage The energy drink was sonicated for 15 min to degas. An aliquot was taken and 1:10 diluted with water. The solution was filtered through a CA syringe filter with 0.45 µm pore size directly into the HPLC vial for injection. Recovery rates were not assessed. 3

Fat-soluble vitamins in the vitamin tablet One vitamin tablet was weighed and ground with a mortar and pestle. The powder was transferred into a 250 ml bottle and the weight noted. Eight milliliters of 80% ethanol solution were added, followed by 10 ml of hexane. The solution was shaken by hand for 10 s and extracted in a sonication bath set at 40 C for 10 min. The solution was then transferred into a 50 ml conical tube for easier layer separation. The hexane layer was taken and filtered through a CA syringe filter with 0.45 µm pore size. One aliquot was used directly for injection and a second aliquot of the hexane layer was diluted 1:10 with hexane. The undiluted and diluted solutions were used for quantification, depending on the amount of analyte in the sample. The same procedure was taken with a placebo tablet. The placebo tablet was analyzed without adding vitamin standard for matrix background subtraction. In addition, it was spiked with 18 µg/ml of a vitamin standard mixture to calculate the recovery rate of each analyte. For this purpose, 1.8 ml of 100 µg/ml standard solution were added and let stand for 3 min. Afterwards 6.2 ml of 80% ethanol solution and 10 ml of hexane were used to come up to the same volume as used for the real samples. The procedure was followed as described for the vitamin tablet. Instrumentation Vanquish Flex Duo system for Dual LC consisting of: System Base (P/N VF-S01-A-02) Dual Pump F (P/N VF-P32-A-01) Dual Split Sampler FT (P/N VF-A40-A-02) Column Compartment H (P/N VH-C10-A-02) with 2 passive pre-heaters, 1 µl (P/N 6732.0174) 2 Diode Array Detectors HL (P/N VH-D-10-A) each equipped with a 10 mm Thermo Scientific LightPipe Flow Cell (P/N 6083.0100) Data acquisition and processing was done with Thermo Scientific Chromeleon 7.2.8 Chromatography Data System (CDS) software. Chromatographic method Figure 1 illustrates the schematic fluidic setup of the Dual LC system used in this study. All samples were prepared in three replicates and analyzed immediately after preparation. Figure 1. Fluidic setup of Vanquish Flex Duo system for Dual LC. 4

Table 1. Chromatographic conditions for WSV. Column: Mobile phase A: Mobile phase B: Acclaim RSLC PolarAdvantage II (150 2.1 mm, 2.2 µm, 120 Å) (P/N 071401) 25 mm potassium dihydrogen phosphate, ph 3.8 (adjusted with phosphoric acid) 70:30 acetonitrile/25 mm potassium dihydrogen phosphate, ph 3.8 Gradient: Time (min) B (%) Flow rate: Temperature: 0 0 5 36 7 36 10 100 14 0 25 0 0.4 ml/min 25 C (with passive pre-heater) Detection Parameters Channel Wavelength [nm] 1 270 2 210 3 245 4 280 3D scan: 190 360 nm Data collection rate: 10 Hz Response time: 0.5 s Other Parameters Injection volume: 1 µl Tray temperature: 5 C Needle wash solvent: 50% methanol Needle wash mode: Both (before and after draw) Table 2. Chromatographic conditions for FSV. Column: Mobile phase A: Mobile phase B: Acclaim RSLC PolarAdvantage II (250 2.1 mm, 2.2 µm, 120 Å) (P/N 074814) DI water Methanol Gradient: Time (min) B (%) Flow rate: Temperature: 0 90 2 96 7.5 96 8.6 100 15 100 15.1 90 25 90 0.4 ml/min 25 C (with passive pre-heater) Detection Parameters Channel Wavelength [nm] 1 325 2 265 3 290 4 280 3D scan: 240 350 nm Data collection rate: 10 Hz Response time: 0.5 s Other Parameters Injection volume: 1 µl Tray temperature: 5 C Needle wash solvent: 50% methanol Needle wash mode: Both (before and after draw) 5

Results and discussion Figure 2 illustrates the separation of a WSV standard on an Acclaim PA2 column with detection at 210 nm. The polar analytes, ascorbic acid and thiamine (peak 1 and 2), are usually poorly retained and are not resolved with conventional reversed-phase columns, but the pair shows adequate retention and resolution with the Acclaim PA2 column. The other critical peak pair, folic acid and cyanocobalamin (peak 7 and 8), is also well separated with Rs > 2.0 (Table 5). Some low-intensity unassigned peaks can be observed both in Figure 2 and Figure 3. The peaks were regarded as unknown impurities found in some of the standard vitamins. As most of the vitamins show different UV absorption, the detection wavelength needs to be optimized to ensure high sensitivity quantitation of all components. The wavelengths used for quantification can be found in Table 3 and Table 4. mau Figure 2. Separation of a water-soluble vitamins standard on an Acclaim PA2 column (150 2.1 mm, 2.2 µm) recorded at 210 nm. The separation of a FSV standard is shown in Figure 3. The resolution was higher than 2 for most pairs. The only exceptions are the pair menaquinone δ-tocopherole (peaks 5 and 6, Rs=1.4) and α-tocopherol acetate γ-tocopherol (peaks 7 and 8, Rs=1). mau 300 250 200 150 100 50 125 100 75 50 0 1 1. Ascorbic acid 2. Thiamine 3. Pyridoxal 4. Pyridoxin 5. Nicotinamide 2 3 4 8 7 1 2 3 4 5 6 7 8 Minutes 2 1 3 4 6. Pantothenic acid 7. Folic acid 8. Cyanocobalamine 9. Riboflavin 5 5 1. Retinol 2. Retinol acetate 3. Ergocalciferol 4. Cholecalciferol 5. Menaquinone 6. δ-tocopherole 25 6 7 8 9 11 0 4.00 5.00 7.50 10.00 12.50 15.00 17.50 19.83 Minutes Figure 3. Separation of a fat-soluble vitamins standard on an Acclaim PA2 column (250 2.1 mm, 2.2 µm) recorded at 280 nm. 6 10 7. α-tocopherole acteate 8. γ-tocopherole 9. α-tocopherole 10. Phyllochinone 11. Retinol palmitate 9 Table 3. UV wavelength used for quantification of WSV. Peak Common Name Chemical Name UV [nm] 1 Vitamin C Ascorbic acid 245 2 Vitamin B1 Thiamine 245 3 Vitamin B6- derivate Pyridoxal 210 4 Vitamin B6 Pyridoxin 210 5 Vitamin B3 Nicotinamide 210 6 Vitamin B5 Pantothenic acid 210 7 Vitamin B9 Folic Acid 280 8 Vitamin B12 Cyanocobalamin 210 9 Vitamin B2 Riboflavin 270 Table 4. UV wavelength used for quantification of FSV. Peak Common Name Chemical Name UV [nm] 1 Vitamin A Retinol 325 2 Vitamin A- derivate Retinol acetate 325 3 Vitamin D2 Ergocalciferol 265 4 Vitamin D Cholecalciferol 265 5 Vitamin K2 Menaquinone 265 6 Vitamin E δ-tocopherole 290 7 Vitamin E- derivate α-tocopherole acetate 280 8 Vitamin E γ-tocopherole 290 9 Vitamin E α-tocopherole 290 10 Vitamin K1 Phyllochinone 265 11 Vitamin A- derivate Retinol palmitate 325 6

Method precision Repeatability tests were carried out by injecting 1 µl of 100 µg/ml standard mixtures of fat- and water-soluble vitamins ten times each. The results are summarized in Table 5 and Table 6. Table 5. Chromatographic results of 10 consecutive injections of a water-soluble vitamins standard mixture with a concentration of 100 µg/ml on an Acclaim PA2 column. WSV RT Avg RT RSD Area RSD Resolution Ascorbic acid 1.27 0.00% 2.69% 3.2 Thiamine 1.50 0.05% 0.28% 6.1 Pyridoxal 2.39 0.04% 0.11% 2.2 Pyridoxin 2.74 0.03% 0.13% 12.2 Nicotinamide 3.95 0.03% 0.12% 10.7 Pantothenic acid 4.76 0.03% 0.12% 8.6 Folic acid 6.59 0.02% 0.13% 2.6 Cyanocobalamin 6.73 0.01% 0.12% 8.0 Riboflavin 7.14 0.02% 0.11% n.a. n.a. = not available Table 6. Chromatographic results of 10 consecutive injections of a fat-soluble vitamins standard mixture with a concentration of 100 µg/ml on an Acclaim PA2 column. FSV RT Avg RT RSD Area RSD Resolution Retinol 4.49 0.14% 0.57% 6.0 Retinol acetate 5.44 0.09% 0.37% 25.1 Ergocalciferol 8.52 0.10% 0.34% 2.2 Cholecalciferol 8.87 0.11% 0.34% 4.4 Menaquinone 9.63 0.11% 0.31% 1.4 δ-tocopherole 9.90 0.13% 0.35% 6.1 α-tocopherole acetate 11.22 0.13% 0.28% 1.0 γ-tocopherole 11.43 0.12% 0.31% 2.3 α-tocopherole 11.85 0.10% 0.28% 3.1 Phyllochinone 13.84 0.07% 0.31% 15.1 Retinol palmitate 16.86 0.05% 0.81% n.a. Both methods show good repeatability. The retention time relative standard deviation (RT RSD) was extremely low for the WSV runs, with values below 0.05%. The retention time of FSVs was slightly less precise, due to the shallow gradient required to achieve good resolution, but still satisfactory. For FSV, the retention time RSD was on the order of 0.1% for most of the peaks. Peak area precision for the WSV was excellent. The RSD was below 0.3% for all peaks except ascorbic acid, which was 2.7%. The relatively low area precision of the ascorbic acid peak is related to the inherent chemical instability of the molecule, which is sensitive to both temperature and light. This is confirmed by the results of these 10 repetitive injections, where the peak area of ascorbic acid steadily decreased injection after injection. The area RSD of the FSV was in general below 0.5%, and slightly higher for retinol and retinol-palmitate. Quantitative determination of water- and fat-soluble vitamins in a vitamin tablet and an energy drink As mentioned in the experimental description above, the quantitation was performed with external standard calibration for all vitamins except thiamine. Thiamine required a different approach because its peak shape was strongly affected by the sample matrix. When thiamine was dissolved in water, the peak was broad and strongly tailed; when the sample was dissolved in the processed placebo, the peak was sharper and integration was easier (results not shown). Additionally, the peak area of a given amount of thiamine was larger when thiamine was dissolved in placebo solution rather than in water. An explanation of this behavior was not found; however, given the strong influence of the sample matrix on the peak shape, a calibration by standard addition was considered more reliable. The calibration range of the analytes was adjusted based on the expected amounts of vitamins in the samples. Table 7 shows the results of the calibration of watersoluble vitamins. The regression coefficients were 0.999 or higher for most vitamins, indicating good linearity. n.a. = not available 7

Table 7. Calibration parameters, sensitivity, and recovery rates for WSVs. WSV Calibration Range Regression Recovery [%] LOD LOQ Ascorbic acid 1 100 0.9955 63 0.019 0.063 Thiamine 5 100 0.9990 22 0.195 0.649 Pyridoxal 5 100 0.9996 101 0.043 0.143 Pyridoxin 1 100 0.9999 100 0.038 0.125 Nicotinamide 1 100 0.9999 101 0.019 0.063 Pantothenic acid 1 100 0.9999 100 0.052 0.172 Folic acid 0.1 100 0.9999 61 0.009 0.029 Cyanocobalamin 5 100 0.9999 105 0.021 0.071 Riboflavin 1 100 0.9929 63 0.008 0.025 The recovery was in general excellent for the vitamins known to be chemically stable. Recovery values were low for ascorbic acid, folic acid, and riboflavin. The low recovery for these molecules can be explained by the low chemical stability. In order to achieve higher recovery values for these unstable molecules, an optimized sample preparation strategy should be developed. For the purpose of this work, the low recovery of the instable molecules was considered acceptable, since the determined amounts were well in agreement with the amount described in the label of the analyzed tablet (Table 9). Thiamine showed low recovery as well. The molecule is considered stable at the conditions of the sample preparation, and the low recovery has a different root cause that could not be pinpointed in the present work. However, similarly to the rest of vitamins, the final calculated amount was in agreement with the labeled amount; therefore, the method was considered acceptable. The FSVs show recovery rates between 81% and 121%, except for retinol, which was 33% (Table 8). Retinol was not detected in the food supplement. In general recovery rates were similar to those reported previously, 3 where a similar sample preparation method is used. 8

Table 8. Calibration parameters, sensitivity, and recovery rates of FSVs. FSV Calibration Range Regression Recovery [%] LOD LOQ Retinol 0.5 100 0.9999 33 0.011 0.036 Retinol acetate 0.1 100 0.9999 90 0.005 0.016 Ergocalciferol 0.1 100 1.0000 86 0.016 0.053 Cholecalciferol 0.1 100 0.9999 92 0.016 0.053 Menaquinone 0.5 100 0.9999 105 0.023 0.077 δ-tocpherole 5 100 0.9999 84 0.150 0.500 α-tocopherole acetate 25 100 0.9997 121 0.500 1.667 γ-tocopherole 10 100 0.9985 110 0.300 1.000 α-tocopherole 10 100 0.9999 102 0.150 0.500 Phyllochinone 1 100 0.9999 105 0.025 0.083 Retinol palmitate 1 100 0.9999 81 0.038 0.125 The whole vitamin tablet was ground and analyzed in triplicate. In a similar manner, a placebo tablet was prepared and its chromatogram used for sample baseline correction. By doing so, matrix and system peaks could be removed from the chromatogram. Figure 4 demonstrates the separation of water-soluble vitamins in the tablet at two different wavelengths (210 nm and 270 nm). Quantitative results can be seen in Table 9. mau 68.6 60.0 50.0 40.0 1 1. Ascorbic acid 2. Thiamine 3. Pyridoxin 4. Nicotinamide 5. Pantothenic acid 6. Folic acid 7. Riboflavin 30.0 5 20.0 10.0 4 7 0.0 2 3 6 0.18 1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.02 Minutes Figure 4. Separation of WSV in tablet. Orange trace: 210 nm; blue trace: 270 nm. Table 9. Quantitative results of WSV in tablet. The measured amount was corrected by recovery rate. WSV Stated Amount on Label [mg/tablet] Measured Amount [mg/tablet] Ascorbic acid 60 61.6 Thiamine 1.4 1.1 Pyridoxal - < 0.005* Pyridoxin 2 2.5 Nicotinamide 18 19.9 Pantothenic acid 6 10.5 Folic acid 0.2 0.4 Cyanocobalamin 0.001 < 0.002* Riboflavin 1.6 3.6 * Peak not observed: value estimated with the LOD corrected by recovery rate 9

Generally higher amounts were measured than those reported in the product label. This apparent mismatch can be explained by the common practice of nutraceutical producers to exceed the declared amount. In this way, the producer can guarantee the labeled amount of vitamin is in the product even as it degrades during the product lifetime. The amount of cyanocobalamin in the sample was less than the limit of detection and could not be determined with this method. The sensitivity of UV detectors is often not sufficient in the sub ng/ml range. To quantify at such a low level, alternative approaches such as sample enrichment are required. 1 Results of the FSV show some discrepancies with the ingredient content declared by the vendor (Figure 5 and Table 10). For example, the ingredient leaflet indicated that the tablet contained 0.6 mg retinol; however, no retinol peak in the sample could be detected, which means the amount must be lower than 0.0002 mg/tablet. Retinol acetate instead was detected at a concentration of 0.9 mg/tablet, whereas in the ingredient leaflet this vitamin is not reported. On the leaflet, α-tocopherole acetate is reported with a concentration of 10 mg/tablet and α-tocopherole with 6.1 mg/tablet. The quantitative results of both analytes show a significantly higher value for α-tocopherole acetate and a significantly lower value for α-tocopherole. Phyllochinone is in good agreement with the stated amount on the label and the measured one. mau 148.8 125.0 100.0 75.0 50.0 25.0 0.0 0.15 2.50 5.00 7.50 10.00 12.50 15.00 Minutes Figure 5. Comparison of the standard mixture (orange) with 100 µg/ml and the vitamin tablet (blue) at a wavelength of 280 nm. Table 10. Quantitative results of FSV in a tablet. The measured amount was corrected by recovery rate. FSV 1. Retinol 2. Retinol acetate 3. Ergocalciferol 4. Cholecalciferol 5. Menaquinone 1 2 6. δ-tocopherole 7. α-tocopherole acteate 8. γ-tocopherole 9. α-tocopherole 7 10. Phyllochinone Stated Amount on Label [mg/tablet] Measured Amount [mg/tablet] Retinol 0.6 < 0.0002* Retinol acetate - 0.9 Ergocalciferol - < 0.0002* Cholecalciferol - < 0.0002* Menaquinone - < 0.0002* δ-tocpherole - < 0.0017* α-tocopherole acetate 10 26.5 γ-tocopherole - < 0.0027* α-tocopherole 6.1 0.4 Phyllochinone 0.03 0.01 Retinol palmitate - < 0.0005* 3 4 5 6 8 9 10 * Peak not observed: value estimated with the LOD corrected by recovery rate 10

The energy drink contains just four out of nine WSVs, namely pyridoxine, nicotinamide, pantothenic acid, and cyanocobalamin (Table 11). The labeled and the calculated amounts show excellent correspondence. Again, cyanocobalamin is added in a concentration below the limit of detection and can therefore not be quantified by this method. Table 11. Quantitative results of WSV in an energy drink. WSV Stated Amount on Label [mg/100 ml] Measured Amount [mg/100 ml] Ascorbic acid - < 0.002* Thiamine - < 0.020* Pyridoxal - < 0.004* Pyridoxin 2 3 Nicotinamide 8 8 Pantothenic acid 2 2 Folic acid - < 0.001* Cyanocobalamin 0.002 < 0.002* Riboflavin - < 0.001* * Peak not observed: value estimated with the LOD Conclusion A method based on the Vanquish Flex Duo system for Dual LC and Acclaim PA2 columns for the quantitative analysis of FSV and WSV in drinks and food supplement tablets was described. The presented workflow enables running two separate methods and columns in one instrument, simultaneously and without additional equipment. The approach provides substantial advantages in terms of throughput and eliminates issues such as solvent incompatibility. The workflow is remarkably easy to set up and operate, unlike previously reported solutions for simultaneous analysis of water- and fat-soluble vitamins. The Acclaim PA2 column proved to be a highly reliable and efficient workhorse for the separation of compounds with a wide range of hydrophobicity. The analysis of the supplement tablet provided vitamin amounts generally higher than those reported in the ingredient leaflet. Additionally, retinol acetate was detected and quantified even though this component was not listed as ingredient by the manufacturer. For the energy drink, the estimated and declared amounts were in excellent agreement. References 1. Thermo Fisher Scientific Technical Note 72488: Determination of water- and fat-soluble vitamins by HPLC. 2. Thermo Fisher Scientific Application Note 252: HPLC Assay of Water-Soluble Vitamins, Fat-Soluble Vitamins, and a Preservative in Dry Syrup Multivitamin Formulation. 3. Choi, C.K.; Dong, M.W. (2005) Sample preparation for HPLC analysis of drug products. In: Ahuja S, Dong MW (eds) Handbook of pharmaceutical analysis by HPLC, 1st edn. Elsevier, Amsterdam, pp 123 143. For Research Use Only. Not for use in diagnostic procedures. Find out more at thermofisher.com/vanquishduo 2018 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise stated. Minisart is a registered trademark of Sartorius Stedim Biotech GMBH Corp. This information is presented as an example of the capabilities of Thermo Fisher Scientific products. It is not intended to encourage use of these products in any manners that might infringe the intellectual property rights of others. Specifications, terms and pricing are subject to change. Not all products are available in all countries. Please consult your local sales representatives for details. AN72592-EN 0218S